This Week in Cardiology cover image

Aug 08 2025 This Week in Cardiology

This Week in Cardiology

00:00

Analysis of the Surpass Cardiovascular Outcomes Trial and Its Implications

This chapter reviews feedback on the Surpass Cardiovascular Outcomes trial, focusing on the comparison between terzepatide and dulaglutide for patients with diabetes and heart disease. It critiques the trial's design and findings while incorporating insights from a diabetes specialist on regulatory necessities and clinical relevance.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app